Mendel Biotechnology and MEDINA to Collaborate
News Jul 23, 2013
Biostimulants are a new category of agricultural chemicals derived from natural sources and applied as seed treatments or foliar applications to improve crop productivity through improved stress tolerance, water and nutrient use efficiency, and overall growth and yield. These natural products can be brought to the market more quickly and with lower regulatory costs than synthetic chemistries.
Under the agreement, MEDINA will provide Mendel with microbial extracts from elite culture collections. Mendel will run its proprietary screens on these collections to identify natural products with crop performance benefits. Those that enhance drought tolerance and increase yield are targeted as the first products from these screens.
"We are very pleased to have identified a partner for the use of our collections to develop novel products for agriculture”, said Olga Genilloud, MEDINA’s Scientific Director. "Mendel’s screening systems offer an outstanding platform to discover novel natural products from our unique collections of microorganisms.”
"We are excited to access collections from MEDINA," said Neal Gutterson, CEO, Mendel. "The screening of their unique collections using Mendel’s proprietary, high throughput Productivity Report Panel will yield new biostimulant products. These new products offer a sustainable, environmentally-friendly means of enhancing crop productivity in broad acre and specialty crops worldwide."
Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain CancerNews
Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.READ MORE
New Drug Class: Potential Therapeutics for Alzheimer’s Disease?News
One step closer to an Alzheimer's treatment? Novel class of drugs more precisely blocks production of toxic forms of beta-amyloid.READ MORE
XenoGesis and Juniper Pharma Services Strengthen AllianceNews
Campanies extend strategic alliance in early drug development services.READ MORE